My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 218

    1.
    2.

    Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.

    Bourne N, Bravo FJ, Francotte M, Bernstein DI, Myers MG, Slaoui M, Stanberry LR.

    J Infect Dis. 2003 Feb 15;187(4):542-9. Epub 2003 Feb 7.PMID: 12599070 [PubMed - indexed for MEDLINE]Related articles

    3.

    Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs.

    Fotouhi F, Soleimanjahi H, Roostaee MH, Dalimi Asl A.

    Iran Biomed J. 2008 Apr;12(2):59-66.PMID: 18506211 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.

    Da Costa XJ, Morrison LA, Knipe DM.

    Virology. 2001 Sep 30;288(2):256-63.PMID: 11601897 [PubMed - indexed for MEDLINE]Related articles

    5.

    Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.

    Fotouhi F, Soleimanjahi H, Roostaee MH, Behzadian F.

    FEMS Immunol Med Microbiol. 2008 Oct;54(1):18-26. Epub 2008 Jul 21.PMID: 18647350 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs.

    Quenelle DC, Collins DJ, Rice TL, Prichard MN, Marciani DJ, Kern ER.

    Antiviral Res. 2008 Nov;80(2):223-4. Epub 2008 Jun 23.PMID: 18573279 [PubMed - indexed for MEDLINE]Related articles

    7.

    Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.

    Corey L, Langenberg AG, Ashley R, Sekulovich RE, Izu AE, Douglas JM Jr, Handsfield HH, Warren T, Marr L, Tyring S, DiCarlo R, Adimora AA, Leone P, Dekker CL, Burke RL, Leong WP, Straus SE.

    JAMA. 1999 Jul 28;282(4):331-40.PMID: 10432030 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.

    Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI.

    J Infect Dis. 2009 Oct 1;200(7):1088-95.PMID: 19702506 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prevalence of herpes simplex virus type 1- and 2- specific antibodies among the acute, recurrent, and provoked types of female genital herpes.

    Hashido M, Lee FK, Nahmias AJ, Kawana T.

    Microbiol Immunol. 1997;41(10):823-7.PMID: 9403510 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1.

    Brans R, Akhrameyeva NV, Yao F.

    J Invest Dermatol. 2009 Oct;129(10):2470-9. Epub 2009 Apr 9.PMID: 19357711 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.

    Chu CF, Meador MG, Young CG, Strasser JE, Bourne N, Milligan GN.

    J Reprod Immunol. 2008 Jun;78(1):58-67. Epub 2007 Oct 24.PMID: 17950908 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.

    Quenelle DC, Collins DJ, Marciani DJ, Kern ER.

    Vaccine. 2006 Mar 6;24(10):1515-22. Epub 2005 Oct 24.PMID: 16288820 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected.

    Bourne N, Milligan GN, Stanberry LR, Stegall R, Pyles RB.

    J Infect Dis. 2005 Dec 15;192(12):2117-23. Epub 2005 Nov 11.PMID: 16288376 [PubMed - indexed for MEDLINE]Related articles

    14.

    Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.

    Natuk RJ, Cooper D, Guo M, Calderon P, Wright KJ, Nasar F, Witko S, Pawlyk D, Lee M, DeStefano J, Tummolo D, Abramovitz AS, Gangolli S, Kalyan N, Clarke DK, Hendry RM, Eldridge JH, Udem SA, Kowalski J.

    J Virol. 2006 May;80(9):4447-57.PMID: 16611905 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.

    Hoshino Y, Dalai SK, Wang K, Pesnicak L, Lau TY, Knipe DM, Cohen JI, Straus SE.

    J Virol. 2005 Jan;79(1):410-8. Erratum in: J Virol. 2005 Apr;79(7):4554. PMID: 15596834 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.
    17.

    Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs.

    Heineman TC, Connelly BL, Bourne N, Stanberry LR, Cohen J.

    J Virol. 1995 Dec;69(12):8109-13.PMID: 7494331 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.

    Linehan MM, Richman S, Krummenacher C, Eisenberg RJ, Cohen GH, Iwasaki A.

    J Virol. 2004 Mar;78(5):2530-6.PMID: 14963155 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.

    Tengvall S, O'Hagan D, Harandi AM.

    Antiviral Res. 2008 Jun;78(3):202-14. Epub 2008 Jan 24.PMID: 18276020 [PubMed - indexed for MEDLINE]Related articles

    20.

    Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.

    McClements WL, Armstrong ME, Keys RD, Liu MA.

    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11414-20.PMID: 8876149 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk